SAN DIEGO, April 3, 2026 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of ImmunityBio, Inc. (NASDAQ: IBRX) publicly traded securities between January 19, 2026 and March 24, 2026, inclusive (the "Class Period"), have until May 26,...
Hence then, the article about investor notice immunitybio inc ibrx investors with substantial losses have opportunity to lead the immunitybio class action lawsuit was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( INVESTOR NOTICE: ImmunityBio, Inc. (IBRX) Investors with Substantial Losses Have Opportunity to Lead the ImmunityBio Class Action Lawsuit )
Also on site :
- Iran-US war latest: Swiss peace talks abruptly cancelled after Trump boasts of Tehran’s ‘unconditional surrender’
- ‘Queen of Country Pop’ Announces New Song Amid 2026 Tour
- World Cup hydration breaks: Ads worth $250m in USA alone, so are they here to stay?